| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_TMEM165_0001600 | Intron-Exon-Intron | chr4:56267820-56284152 | chr4:55401653-55417985 | 183 nt | 0.3880 |
| hsa_TMEM165_0001900 | Intron-Exon-Intron | chr4:56269403-56272629 | chr4:55403236-55406462 | 250 nt | 0.3000 |
| hsa_TMEM165_0002300 | Intron-Exon-Intron | chr4:56269403-56274262 | chr4:55403236-55408095 | 103 nt | 0.3786 |
| hsa_TMEM165_0002000 | Intron-Exon-Intron | chr4:56269403-56275239 | chr4:55403236-55409072 | 250 nt | 0.3520 |
| hsa_TMEM165_0002100 | Intron-Exon-Intron | chr4:56269403-56276557 | chr4:55403236-55410390 | 250 nt | 0.3080 |
| hsa_TMEM165_0002200 | Intron-Exon-Intron | chr4:56269403-56282324 | chr4:55403236-55416157 | 250 nt | 0.3840 |
| hsa_TMEM165_0002400 | Intron-Exon-Intron | chr4:56269403-56284331 | chr4:55403236-55418164 | 123 nt | 0.4553 |
| hsa_TMEM165_0002500 | Exon-Exon | chr4:56269403-56290810 | chr4:55403236-55424643 | 209 nt | 0.4545 |
| hsa_chr4_0486400 | Intergenic-Intergenic | chr4:56270431-56271124 | chr4:55404264-55404957 | 694 nt | 0.4222 |
| hsa_TMEM165_0002600 | Intron-Exon | chr4:56275112-56278006 | chr4:55408945-55411839 | 128 nt | 0.4688 |
A study in humans demonstrated that the circTMEM165 (hsa_circ_0001414) was significantly upregulated in the peripheral blood of myocardial infarction patients compared to healthy controls, as identified by RNA sequencing and validated by RT-qPCR [Li et al. DOI:10.3389/fcvm.2022.810257]. A study in human patients with ST-segment elevation myocardial infarction (STEMI) identified the circTMEM165 as a differentially expressed circular RNA in peripheral blood, a finding that was confirmed in an AC16 cell model [Wang et al. DOI:10.1515/med-2023-0807].